Primary Age-Related Tauopathy in Human Subcortical Nuclei

Primary Age-Related Tauopathy in Human Subcortical Nuclei

The present study aimed to determine the spatial distribution patterns of hyperphosphorylated tau-immunoreactive cells in subcortical nuclei of post-mortem human brain with primary age-related tauopathy (PART). Subcortical tauopathy has important pathological and clinical implications. Expression of...

Full description

Bibliographic Details
Main Authors:	Keqing Zhu, Xin Wang, Bing Sun, Juanli Wu, Hui Lu, Xiaoling Zhang, Huazheng Liang, Dandan Zhang, Chong Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-05-01
Series:	Frontiers in Neuroscience
Subjects:	primary age-related tauopathy subcortical nuclei Alzheimer’s disease neurofibrillary tangle brainstem brain bank
Online Access:	https://www.frontiersin.org/article/10.3389/fnins.2019.00529/full

Similar Items

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
by: Tomas Smolek, et al.
Published: (2019-12-01)

Corrigendum: Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy
by: Tomas Smolek, et al.
Published: (2020-02-01)

Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model
by: Joshua T. Emmerson, et al.
Published: (2023-08-01)

Pathology of different tau protein species in neurodegenerative diseases: Alzheimer’s disease, corticobasal degeneration, and progressive supranuclear palsy
by: Mohammad Majidi, et al.
Published: (2021-07-01)

Expression Pattern of p62 in Primary Age-Related Tauopathy: Staging of p62 in PART
by: Xin Wang, et al.
Published: (2022-04-01)

Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis
by: Heather M. Terron, et al.
Published: (2024-04-01)

Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice
by: Inbal Lahiani-Cohen, et al.
Published: (2020-01-01)

Are tau aggregates toxic or protective in tauopathies?
by: Catherine M Cowan, et al.
Published: (2013-08-01)

Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment
by: Gabriel A. Marx, et al.
Published: (2022-10-01)

The longitudinal volumetric and shape changes of subcortical nuclei in Parkinson’s disease
by: Wenyi Yang, et al.
Published: (2024-03-01)

High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer’s disease using computational approaches
by: Rohit Shukla, et al.
Published: (2021-05-01)

Effects of resveratrol and morin on insoluble tau in tau transgenic mice
by: Yu Kwun Chung, et al.
Published: (2018-11-01)

Volumetric and Diffusion Abnormalities in Subcortical Nuclei of Older Adults With Cognitive Frailty
by: Mingyue Wan, et al.
Published: (2020-07-01)

RNA binding proteins co-localize with small tau inclusions in tauopathy
by: Brandon F. Maziuk, et al.
Published: (2018-08-01)

Aducanumab: A new hope in Alzheimer's disease
by: Rouchan Ali, et al.
Published: (2022-09-01)

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease
by: Nicolas Sergeant, et al.
Published: (2019-09-01)

Neuroprotective Effects of Green Tea Seed Isolated Saponin Due to the Amelioration of Tauopathy and Alleviation of Neuroinflammation: A Therapeutic Approach to Alzheimer’s Disease
by: Muhammad Imran Khan, et al.
Published: (2022-03-01)

Neurodegeneration Within the Amygdala Is Differentially Induced by Opioid and HIV-1 Tat Exposure
by: Sara R. Nass, et al.
Published: (2022-05-01)

Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
by: Minghui Wang, et al.
Published: (2023-03-01)

Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy
by: Naruhiko Sahara, et al.
Published: (2023-04-01)

The Significance of Tau Aggregates in the Human Brain
by: Rudy J. Castellani
Published: (2020-12-01)

Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.
by: Rebecca L. Kow, et al.
Published: (2021-01-01)

Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches
by: Ayomide Victor Atoki, et al.
Published: (2023-09-01)

Factors Associated With the Occurrence and Evolution of Recent Small Subcortical Infarcts (RSSIs) in Different Locations
by: Hui Hong, et al.
Published: (2020-08-01)

Okadaic acid induces damage of human neuroblastoma cell line SH-SY5Y
by: LU Ya-lan, ZHOU Li, HAN Yun-lin, WANG Ke-wei, QIN Chuan
Published: (2022-06-01)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
by: Yuxing Xia, et al.
Published: (2020-06-01)

Alzheimer’s disease: A Threat to mankind
by: Poorti Pandey, et al.
Published: (2011-12-01)

The neuropathological diagnosis of Alzheimer’s disease
by: Michael A. DeTure, et al.
Published: (2019-08-01)

de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia
by: Kunie Ando, et al.
Published: (2020-06-01)

Distinct atrophy of septal nuclei in Parkinson’s disease
by: Niloufar Kamalkhani, et al.
Published: (2022-01-01)

The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer’s Disease
by: Filippo S. Giorgi, et al.
Published: (2017-09-01)

Dynamic modulation of activity in cerebellar nuclei neurons during pavlovian eyeblink conditioning in mice
by: Michiel M ten Brinke, et al.
Published: (2017-12-01)

Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link
by: Andrea González, et al.
Published: (2022-04-01)

Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
by: Adrian Florian Bălașa, et al.
Published: (2020-10-01)

Transfusion with Blood Plasma from Young Mice Affects rTg4510 Transgenic Tau Mice Modeling of Alzheimer’s Disease
by: Carlos M. Hernandez, et al.
Published: (2023-05-01)

Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds
by: Marta Perez-Rando, et al.
Published: (2020-10-01)

Fluctuations in neurofibrillary tangle density in Alzheimer’s disease revealed by Fourier (spectral) analysis
by: Richard Armstrong
Published: (2021-01-01)

Activation of Caspase-8 in the Alzheimer's Disease Brain
by: Troy T. Rohn, et al.
Published: (2001-12-01)

Vitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer’s disease
by: Mehrdad Jahanshahi, et al.
Published: (2020-01-01)

Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
by: Md. Sahab Uddin, et al.
Published: (2019-09-01)